Diclofenac Potassium SR Pellets Manufacturer in India

Diclofenac Potassium SR Pellets (CAS No: 15307-81-0)

Pharmaceutical-Grade Sustained Release Pellets for Oral Dosage Forms

Diclofenac Potassium SR Pellets are pharmaceutical sustained-release multiparticulate pellets containing Diclofenac Potassium, designed for modified-release oral dosage-form applications. These pellets can be used as pharmaceutical formulation intermediates for sustained-release capsules and other suitable multiparticulate oral dosage forms where controlled drug release is required.

Diclofenac Potassium is the potassium salt of diclofenac and is identified by CAS Number 15307-81-0. The compound has the molecular formula C₁₄H₁₀Cl₂KNO₂ and a molecular weight of 334.24 g/mol. The USP monograph defines Diclofenac Potassium as containing 99.0%–101.0% of diclofenac potassium on the dried basis for the API. This API assay should not be confused with the drug loading of finished Diclofenac Potassium SR Pellets.

Diclofenac Potassium SR Pellets are designed as multiparticulate systems in which formulation and release-controlling components can be used to establish the desired sustained-release characteristics. Commercial pharmaceutical pellet manufacturers currently list Diclofenac Potassium SR Pellets with different drug-loading levels, demonstrating that the final pellet composition is formulation-specific.

Key Features

• Diclofenac Potassium sustained-release multiparticulate formulation
• Designed for controlled and sustained drug-release applications
• Suitable for pharmaceutical capsule-filling applications
• Suitable for modified-release oral dosage-form development
• Product-specific drug loading and dissolution profile
• Flexible formulation platform for pharmaceutical development
• Suitable for bulk pharmaceutical pellet applications

Applications

• Sustained-release capsule formulations
• Multiparticulate oral dosage forms
• Modified-release pharmaceutical formulations
• Pharmaceutical capsule filling
• Oral solid dosage-form development
• Pharmaceutical formulation development
• Drug-loaded sustained-release pellets
• Bulk pharmaceutical formulation applications

Why Choose Diclofenac Potassium SR Pellets?

• Sustained-release multiparticulate platform containing Diclofenac Potassium
• Suitable for controlled-release formulation development
• Designed for oral dosage-form applications
• Suitable for capsule-based multiparticulate formulations
• Product-specific drug loading and dissolution characteristics
• Quality evaluation can include identification, assay/drug content, related substances, moisture and dissolution testing
• Suitable for pharmaceutical formulation and bulk supply requirements

Packaging & Supply

Diclofenac Potassium SR Pellets can be supplied in suitable pharmaceutical packaging for formulation development and bulk manufacturing applications. Packaging configuration, drug loading, pellet characteristics, dissolution profile, quantity and storage requirements should be confirmed according to the applicable product specification and customer requirements.

Get Bulk Quote via WhatsApp